347 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
lease liabilities
Deferred revenue
2023 convertible senior notes, net
Total current liabilities
Long-term contingent liabilities
Long-term operating … lease liabilities
Long-term deferred revenue
Deferred income taxes, net
Other long-term liabilities
Total liabilities
Total stockholders
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
portfolio of assets that are expected to drive future revenue growth. We look forward to sharing our long term financial forecast at our upcoming … nephropathy ("IgAN"). FILSPARI demonstrated long-term kidney function preservation and achieved a clinically meaningful difference in estimated glomerular
8-K
EX-99.1
gm107syg8 5z
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
49gv7pkt6
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
l4zdpt otqzlf
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
9fnsoy0
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
ortutg7 u0b
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
x6h0pk bvjgab
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
S-3ASR
EX-1.2
lmrj r0bbr
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
so6titmk56wc3v
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
ft5hnn
5 May 22
Business combination disclosure
7:30am